Skip to content
10-K

Annual Report

BioRestorative Therapies, Inc. BRTX

0001641172-25-001011

← back to feed
Filed
Mar 28, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 26, 2025 7.5M sh
Total Liabilities FY 2024 · Dec 31, 2024 $3.75M
Gross Profit FY 2024 · Dec 31, 2023 $145.8K